{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:26:41Z","timestamp":1783445201374,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jbiotec.2026.05.009","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:48:39Z","timestamp":1779205719000},"page":"67-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual-functional chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted Bcl-2 siRNA delivery and photothermal therapy in bladder cancer"],"prefix":"10.1016","volume":"417","author":[{"given":"Xin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.009_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12032-025-02613-8","article-title":"Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment","volume":"42","author":"Abulsoud","year":"2025","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.jbiotec.2026.05.009_bib2","first-page":"559","article-title":"\"Cytotoxic and antimicrobial analysis of biosynthesized selenium nanoparticles from Solanum tuberosum peels","volume":"9","author":"Aktepe","year":"2025","journal-title":"Int. J. Agric. Environ. Food Sci."},{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.009_bib3","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/acsami.3c11772","article-title":"Urease-powered black TiO2 micromotors for photothermal therapy of bladder cancer","volume":"16","author":"Amiri","year":"2024","journal-title":"ACS Appl. Mater. & Interfaces"},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.009_bib4","first-page":"68","article-title":"\"Banana Peel-Assisted Synthesis of ZnS and 5 mol% Mg-Doped ZnS for Photocatalytic Degradation of Congo Red.\"","volume":"11","author":"BALNAN","year":"2026","journal-title":"MAS J. Appl. Sci."},{"issue":"9","key":"10.1016\/j.jbiotec.2026.05.009_bib5","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/cancers13092214","article-title":"Nanotechnology in bladder cancer: diagnosis and treatment","volume":"13","author":"Barani","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.009_bib6","first-page":"801","article-title":"\"Sustainable Nanoparticle Synthesis of Palladium and Platinum Using Mung Bean (Vigna radiata L.) for Circular Metal Recovery","volume":"9","author":"\u00c7ene","year":"2025","journal-title":"Int. J. Agric. Environ. Food Sci."},{"issue":"14","key":"10.1016\/j.jbiotec.2026.05.009_bib7","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.7150\/ijbs.48358","article-title":"Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch\/Jagged2 suppresses the Bladder Tumorigenesis via inhibiting PI3K\/AKT\/mTOR\/MMPs signaling","volume":"16","author":"Chen","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.009_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4068\/cmj.2022.58.3.102","article-title":"Silver nanoparticles exert apoptotic activity in bladder cancer 5637 cells through alteration of Bax\/Bcl-2 genes expression","volume":"58","author":"Daei","year":"2022","journal-title":"Chonnam Med. J."},{"issue":"10","key":"10.1016\/j.jbiotec.2026.05.009_bib9","first-page":"169","article-title":"The diagnosis and treatment of patients with bladder carcinoma","volume":"118","author":"De Wit","year":"2021","journal-title":"Dtsch. \u00c4rzteblatt Int."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.009_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12951-025-03511-x","article-title":"Genetically engineered T cell membrane-camouflaged nanoparticles triggered cuproptosis for synergistic bladder cancer photothermal-immunotherapy","volume":"23","author":"Deng","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"6","key":"10.1016\/j.jbiotec.2026.05.009_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/cancers16061195","article-title":"CD44 in bladder cancer","volume":"16","author":"Duex","year":"2024","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.jbiotec.2026.05.009_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/0284186X.2021.1915498","article-title":"Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer","volume":"60","author":"Fabiano","year":"2021","journal-title":"Acta Oncol."},{"key":"10.1016\/j.jbiotec.2026.05.009_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216606","article-title":"Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer","volume":"585","author":"Fukushima","year":"2024","journal-title":"Cancer Lett."},{"issue":"14","key":"10.1016\/j.jbiotec.2026.05.009_bib14","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.3390\/ijms241411852","article-title":"Sertindole, an antipsychotic drug, curbs the STAT3\/BCL-xL axis to elicit human bladder cancer cell apoptosis in vitro","volume":"24","author":"Hsu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.jbiotec.2026.05.009_bib15","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.3390\/cancers14133181","article-title":"Advances in diagnosis and therapy for bladder cancer","volume":"14","author":"Hu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jbiotec.2026.05.009_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155680","article-title":"BCL-2 and \u03b3-H2AX immunostaining profile in urothelial bladder cancer prognosis","volume":"264","author":"Kawasaki","year":"2024","journal-title":"Pathol. -Res. Pract."},{"issue":"2","key":"10.1016\/j.jbiotec.2026.05.009_bib17","article-title":"Designing intelligent nanomaterials to achieve highly sensitive diagnoses and multimodality therapy of bladder cancer","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"issue":"2","key":"10.1016\/j.jbiotec.2026.05.009_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/acsbiomaterials.1c01217","article-title":"Fe (iii)-doped polyaminopyrrole nanoparticle for imaging-guided photothermal therapy of bladder cancer","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Biomater. Sci. & Eng."},{"issue":"40","key":"10.1016\/j.jbiotec.2026.05.009_bib19","doi-asserted-by":"crossref","first-page":"46668","DOI":"10.1021\/acsami.3c09564","article-title":"Hyaluronic acid-conjugated fluorescent probe-shielded polydopamine nanomedicines for targeted imaging and chemotherapy of bladder cancer","volume":"15","author":"Qiu","year":"2023","journal-title":"ACS Appl. Mater. & Interfaces"},{"issue":"4","key":"10.1016\/j.jbiotec.2026.05.009_bib20","first-page":"263","article-title":"NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression","volume":"31","author":"Ruixiao","year":"2021","journal-title":"China Oncol."},{"issue":"12","key":"10.1016\/j.jbiotec.2026.05.009_bib21","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1021\/acsabm.2c00558","article-title":"Nontoxic natural polymeric particle vehicles derived from hyaluronic acid and mannitol as mitomycin c carriers for bladder cancer treatment","volume":"5","author":"Sahiner","year":"2022","journal-title":"ACS Appl. bio Mater."},{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.009_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/nnm-2022-0198","article-title":"Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer","volume":"18","author":"Shahidi","year":"2023","journal-title":"Nanomedicine"},{"issue":"48","key":"10.1016\/j.jbiotec.2026.05.009_bib23","doi-asserted-by":"crossref","first-page":"17929","DOI":"10.1039\/D2NR04200B","article-title":"NIR-II-triggered doxorubicin release for orthotopic bladder cancer chemo-photothermal therapy","volume":"14","author":"Sun","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.jbiotec.2026.05.009_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.778973","article-title":"Functional nanomedicines for targeted therapy of bladder cancer","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.009_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7150\/thno.88550","article-title":"Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy","volume":"14","author":"Tang","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.009_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40820-025-01717-0","article-title":"Multifunctional and Scalable Nanoparticles for Bimodal Image-Guided Phototherapy in Bladder Cancer Treatment","volume":"17","author":"Tang","year":"2025","journal-title":"Nano-Micro Lett."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.009_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1039\/C9BM01377F","article-title":"Targeted multifunctional nanomaterials with MRI, chemotherapy and photothermal therapy for the diagnosis and treatment of bladder cancer","volume":"8","author":"Tao","year":"2020","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.jbiotec.2026.05.009_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.jbiotec.2026.05.009_bib29","doi-asserted-by":"crossref","first-page":"24388","DOI":"10.1021\/acsanm.4c03916","article-title":"Targeting ERCC2 with siRNA Self-Assembled Nanoparticles to Enhance the Cisplatin Response in Bladder Cancer","volume":"7","author":"Wang","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"issue":"19","key":"10.1016\/j.jbiotec.2026.05.009_bib30","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.3390\/ijms251910388","article-title":"Nanomedicine in bladder cancer therapy","volume":"25","author":"Winnicka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jbiotec.2026.05.009_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4103\/kleuhsj.kleuhsj_582_22","article-title":"Cluster of differentiation 44 and matrix metalloproteinase 2 markers: A prospective study and insight to their role in bladder cancer","volume":"16","author":"Yadav","year":"2023","journal-title":"Indian J. Health Sci. Biomed. Res. kleu"},{"issue":"13","key":"10.1016\/j.jbiotec.2026.05.009_bib32","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.7150\/ijms.60399","article-title":"Antitumor activity of small activating RNAs induced PAWR gene activation in human bladder cancer cells","volume":"18","author":"Yang","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.05.009_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/pharmaceutics15010211","article-title":"The progress of chitosan-based nanoparticles for intravesical bladder cancer treatment","volume":"15","author":"Yu","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165626001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165626001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:01:10Z","timestamp":1783443670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165626001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S0168165626001628"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2026.05.009","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-functional chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted Bcl-2 siRNA delivery and photothermal therapy in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2026.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}